Regarding glucose-lowering therapy, insulin and sulfonylureas are common, while SGLT2i (0.4%) and GLP-1RA (4%) are underused, reflecting the pre-2019 timeline
9 , e002208 (2021)
The study in Nature Medicine did not report on eye diseases, however, says Aleksandra Rachitskaya, MD, a vitreoretinal surgeon at the Cole Eye Institute
When confronted with evidence that conflicts with that truth, we are going to for the most part ignore that evidence or write it off as some weird human subgroup and make no attempt to learn whether or not we are fooling ourselves, which should be the one thing we're always foremost in our mind
No Medical or Professional Advice Site content, product descriptions, literature references, research summaries, customer support, and Certificates of Analysis are provided for general laboratory and informational purposes
Kleinridders and Pothos, 2019)